News and Press Releases

Touchlight to Supply GMP dbDNA to Support University of Nottingham’s Clinical Study for a Next-Generation Vaccine for Zika Virus

21 August 2024 -- Hampton, UK -- Touchlight, an innovation-driven contract development and manufacturing organization (CDMO) specializing in enzymatic DNA production, is proud to announce the clinical supply of its proprietary...

Category: Biotechnology, Clinical Trials, Drug Discovery, Pharmaceutical
Posted: August 21, 2024

Morelands & Riverdale Buildings Lower Sunbury Road Hampton TW12 2ER

Touchlight and GSK Sign License Agreement for Use of Enzymatic dbDNA Production Technology for mRNA Manufacturing

Agreement enables GSK access to enzymatic production technology for rapid GMP production of DNA template for mRNA vaccine manufacturing 23 July 2024 -- Hampton, UK -- Touchlight, an innovation-driven CDMO...

Category: BioManufacturing, Biotechnology, Other, Pharmaceutical
Posted: July 23, 2024

Morelands & Riverdale Buildings Lower Sunbury Road Hampton TW12 2ER

Touchlight and LenioBio Collaborate to Accelerate Development of Protein Therapeutics for Pandemic Response

Touchlight to participate in LenioBio’s recently announced grant from CEPI 2 July 2024 -- Hampton, UK, and Düsseldorf, Germany -- LenioBio, a biotech company pioneering cell-free protein production, and Touchlight,...

Category: BioManufacturing, Biotechnology, Other, Pharmaceutical
Posted: July 2, 2024

Morelands & Riverdale Buildings Lower Sunbury Road Hampton TW12 2ER

ELRIG UK and The Protein Society Partner to Advance Protein Sciences in Drug Discovery

Partners to host joint conference on ‘Protein Sciences in Drug Discovery’ in Cambridge, UK, from 18–19 November 2024 26 June 2024 -- Cambridge, UK and California, US -- The European...

Category: Biotechnology, Drug Discovery, Pharmaceutical
Posted: June 26, 2024

ELRIG (UK) Ltd. Salisbury House, Station Road, Cambridge, CB1 2LA, UK

NEOsphere Biotechnologies Partners with Kymera Therapeutics for Novel Molecular Glue Target Discovery

14 May 2024 -- Martinsried, Germany -- NEOsphere Biotechnologies, a German biotechnology company pioneering high-throughput proteomics to systematically build broad and unique portfolios of novel degrader targets at scale, today...

Category: Drug Discovery, Pharmaceutical
Posted: May 14, 2024

Fraunhoferstrasse 1 82152 Planegg Germany

University of Liverpool to Use Touchlight’s Rapid Enzymatic dbDNA in Fully Personalised Neoantigen Cancer Vaccine Clinical Study

The UK’s Medical Research Council is funding a 10-patient phase 1 study to deliver rapid personalised treatment for lung cancer patients 3 April 2024 -- Hampton, UK -- Touchlight, a...

Category: Biotechnology, Clinical Trials
Posted: April 3, 2024

Morelands & Riverdale Buildings Lower Sunbury Road Hampton TW12 2ER

Touchlight Awarded Tender to Supply Enzymatic dbDNA to CPI’s RNA Centre of Excellence

28 March 2024 -- Hampton, UK -- Touchlight, an innovation-driven CDMO enabling the development of genetic medicines with its doggybone DNA (dbDNA) technology and leaders in enzymatic DNA production, is...

Category: Biotechnology
Posted: March 28, 2024

Morelands & Riverdale Buildings Lower Sunbury Road Hampton TW12 2ER

X-Chem and Structural Genomics Consortium Enter Into Collaboration to Unlock the Human Proteome and Promote Open Science

28 September 2023 -- Massachusetts, US -- X-Chem, a global leader in innovative drug discovery services, and the Structural Genomics Consortium (SGC), a public-private partnership dedicated to accelerating drug discovery through...

Category: Biotechnology
Posted: September 28, 2023

100 Beaver Street Waltham, MA 02453